Randomised Controlled Trial of Alemtuzumab and Tacrolimus Monotherapy with Daclizumab, Tacrolimus and Mycophenolate Mofetil in Renal Transplantation.

被引：0
|
作者：
Chan, K. [1 ]
Galliford, J. [1 ]
Goodall, D. [1 ]
Charif, R. [1 ]
Dorling, A. [1 ]
Warrens, A. [1 ]
Hakim, N. [1 ]
Papalois, V. [1 ]
Taube, D. [1 ]
McLean, A. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, W London Renal & Transplant Ctr, Kidney & Transplant Inst, London, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [21] Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil
    Washburn, K
    Speeg, KV
    Esterl, R
    Cigarroa, F
    Pollack, M
    Tourtellot, C
    Maxwell, P
    Halff, G
    TRANSPLANTATION, 2001, 72 (10) : 1675 - 1679
  • [22] Comparison of Histological Features in 1-Year Surveillance Biopsies in a Randomized Controlled Trial of Daclizumab/Tacrolimus/MMF Versus Alemtuzumab/Tacrolimus Monotherapy.
    Roufosse, C.
    Smith, A. P. T.
    Chan, K.
    Cairns, T.
    Cook, H. T.
    Taube, D.
    Mclean, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 49 - 49
  • [23] 12 month results of a multicenter, randomized trial comparing three induction agents (alemtuzumab, thymoglobulin and basiliximab) with tacrolimus, mycophenolate mofetil and a rapid steroid withdrawal in renal transplantation.
    Hanaway, Michael
    Woodle, E. Steve
    Mulgaonkar, Shamkant
    Peddi, Ram
    Harrison, Gilda
    Vandeputte, Karen
    Fitzsimmons, William
    First, Roy
    Holman, John
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 215 - 215
  • [24] Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy
    Tan, H. P.
    Kaczorowski, D. J.
    Basu, A.
    Unruh, M.
    McCauley, J.
    Wu, C.
    Donaldson, J.
    Dvorchik, I.
    Kayler, L.
    Marcos, A.
    Randhawa, P.
    Smetanka, C.
    Starzl, T. E.
    Shapiro, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (10) : 2409 - 2417
  • [25] Final 36 Month Results of a Randomized Trial Comparing Three Induction Agents (Alemtuzumab, Thymoglobulin and Basiliximab) with Tacrolimus, Mycophenolate Mofetil and Rapid Steroid Withdrawal in Renal Transplantation.
    Peddi, Ram
    Hanaway, Michael
    Woodle, Steve
    Mulgaonkar, Shamkant
    Harrison, Gilda
    Vandeputte, Karen
    Fitzsimmons, William
    First, Roy
    Holman, John
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 49 - 49
  • [26] Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation
    Shapiro, R.
    Ellis, D.
    Tan, H. P.
    Moritz, M. L.
    Basu, A.
    Vats, A. N.
    Kayler, L. K.
    Erkan, E.
    McFeaters, C. G.
    James, G.
    Grosso, M. J.
    Zeevi, A.
    Gray, E. A.
    Marcos, A.
    Starzl, T. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (12) : 2736 - 2738
  • [27] A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone mycophenolate mofetil in renal transplant recipients
    Shapiro, R
    Jordan, ML
    Scantlebury, VP
    Vivas, C
    Marsh, JM
    McCauley, J
    Johnston, J
    Randhawa, P
    Irish, W
    Gritsch, HA
    Naraghi, R
    Hakala, TR
    Fung, JJ
    Starzl, TE
    TRANSPLANTATION, 1999, 67 (03) : 411 - 415
  • [28] Steroid free monotherapy with either tacrolimus, Sirolimus or mycophenolate mofetil after kidney transplantation
    Geel, Annemarie
    van Gurp, Eveline
    Hendrikx, Thijs
    Landman, Tineke
    Kai, Judith
    Weimar, Willem
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 579 - 579
  • [29] Continuing 24 Month Results of a Multicenter, Randomized Trial Comparing Three Induction Agents (Alemtuzumab, Thymoglobulin and Basiliximab) with Tacrolimus, Mycophenolate Mofetil and a Rapid Steroid Withdrawal in Renal Transplantation.
    Mulgaonkar, Shamkant
    Hanaway, Michael
    Woodle, E. Steve
    Peddi, Ram
    Harrison, Gilda
    Vandeputte, Karen
    Fitzsimmons, William
    First, Roy
    Holman, John
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 282 - 282
  • [30] Daclizumab induction/tacrolimus sparing: a randomized prospective trial in renal transplantation
    Light, JA
    Sasaki, TM
    Ghasemian, R
    Barhyte, DY
    Fowlkes, DL
    CLINICAL TRANSPLANTATION, 2002, 16 : 30 - 33
12345